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both operative and nonoperative treatment of ankle fractures in the geriatric population reflected unacceptably high complication rates 9, 10 . More recently, multiple retrospective series of geriatric ankle fractures treated by modern methods demonstrated improved short-term outcomes and complication rates similar to those of younger cohorts [11] [12] [13] [14] [15] [16] [17] . However, to our knowledge, very few data are available concerning the one-year morbidity and mortality of geriatric patients with ankle fractures. In contrast, the one-year mortality and morbidity associated with hip fractures is well documented.
Multiple hip fracture studies have demonstrated a one-year mortality of up to 30% 18, 19 . In 2011, Shivaranthre et al. reported on a retrospective series on ninety-two operative ankle fractures of patients who were older than eighty years of age 12 . They found 82% of patients returning to pre-injury mobility by three to six months post-injury but also a 12% one-year postoperative mortality rate 12 . Koval et al. used a 20% sample of Medicare Part B claims data, representing patients who are sixty-five years of age and older, and similarly demonstrated an 8.4% one-year mortality rate after ankle fracture 20 . The purpose of this study was to better characterize the morbidity and mortality of ankle fractures in the elderly population. Hip fractures were chosen as a comparator because of the substantial literature that has been dedicated to this injury in the geriatric population. To more evenly compare with patients with hip fracture and to select geriatric patients who were physiologically elderly, we selected patients who required a hospitalization after their ankle injury. As the population older than sixty-five years of age increasingly includes physiologically younger individuals who may not need inpatient hospitalization after an ankle fracture, this study intentionally excluded those patients.
We hypothesized that, despite modern treatment advances, geriatric ankle fractures are associated with significant one-year morbidity and mortality. In spite of this, these fractures have not garnered the same public health attention as geriatric hip fractures. We proposed this hypothesis understanding that evidence suggests that geriatric ankle fractures tend to occur in a cohort of younger, heavier, and more active individuals compared with their counterparts with hip fracture 8, [21] [22] [23] . However, ankle fractures in geriatric patients frequently pose technical challenges that may be more difficult to manage than in patients with hip fracture secondary to tenuous soft-tissue envelopes and osteopenic bone. This study is not designed to specifically investigate the potential wound or fixation complications. However, these fractures frequently require prolonged distal extremity immobilization and non-weight-bearing, placing additional stresses on these patients, which we hypothesized might increase morbidity and mortality.
Materials and Methods

F
ollowing institutional review board approval, access to complete (100%) 2008 data from the Centers for Medicare and Medicaid Services was obtained through Data Use Agreement #25776. Medicare Part A claims were used to select for inpatient admissions. Codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) were used to create two cohorts reflecting patients with new diagnoses of ankle fractures (824.0-824.9) and hip fractures (820.0-820.9). Patients younger than sixty-five years of age at the time of their diagnosed injury were excluded to only select geriatric patients. Patients in each cohort who had sustained a previous fracture of the same type in the preceding year were excluded to eliminate any confounding by the previous injury. All Medicare inpatient admissions in 2008 for any reason other than ankle or hip fractures served as a control cohort.
The primary outcome measure selected was the one-year post-injury mortality. Each Medicare beneficiary is represented by a unique Denominator Flowchart of inclusion criteria for geriatric ankle and hip fracture cohorts.
File, which contains the requisite demographic characteristics, including date of birth and date of death. Mortality rates for patients with ankle fracture were evaluated by decade of life in comparison with patients with hip fracture and all other admission cohorts.
As ankle fractures and hip fractures are believed to occur in nonequivalent cohorts of geriatric patients, age differences and preexisting conditions could therefore confound the primary outcome of mortality. Age subgroup analysis was therefore performed to account for the difference in age distribution. To identify differences in preexisting health status, the mean Elixhauser and Charlson-Deyo comorbidity indices were determined on the basis of ICD-9-CM codes prior to injury 24, 25 . Finally, Cox regression multivariate analysis was performed to isolate the relative contributions of the injury, ankle or hip fracture, to one-year mortality independent of age and comorbidities.
Secondary outcome measures were focused on injury morbidity as represented by length of inpatient hospitalization, discharge to nursing home, readmissions, and medical complications. The primary claim file was analyzed for inpatient length of stay. The Minimum Data Set, a required form upon admission to a nursing home, was used to determine discharge to nursing home. Readmissions within thirty days and complications within ninety days following the definitive fracture claim were determined by linking the Denominator File to further claims. To exclude transfers between facilities from being represented as readmissions, additional admission claims were counted as readmissions only if there was a minimum one-day separation from a previous discharge. The following medical complications were identified by their respective ICD-9-CM codes: surgical site infection, deep venous thrombosis, pulmonary embolism, congestive heart failure, pneumonia, urinary tract infection, pressure ulcer, myocardial infarction, Clostridium difficile infection, and gastrointestinal bleeds (Table I) .
Statistical Analysis
Cohort characteristics were summarized by calculating both means and standard deviations for the continuous variables as well as frequency distributions for the categorical variables. Unadjusted Cox proportional hazard survival models were used to examine the one-year mortality for each cohort. Age-adjusted, Elixhauser score-adjusted, and both age and Elixhauser score-adjusted models were built. All statistical analysis was performed with use of SAS version 9.3 (SAS Institute, Cary, North Carolina).
Source of Funding
There were no external funding sources for this study.
Results
A mong the more than 7 million patients identified with a Medicare fee-for-service inpatient Part A claim in 2008, we identified 19,648 patients who were sixty-five years of age or older, had been diagnosed with an ankle fracture in 2008, and had not had an ankle fracture inpatient admission in 2007. We identified 193,980 patients with hip fracture meeting the same criteria to serve as the comparison group (Fig. 1 ). There were 180 patients who sustained both an ankle fracture and a hip fracture in 2008, and these patients were included in both cohorts. The control cohort of Medicare patients older than sixty-five years of age admitted with any diagnosis other than a hip or ankle fracture included 5,801,831 patients. The cohorts differed significantly (p < 0.001) with respect to mean age, sex, and comorbidity burden (Table II) . The ankle fracture cohort was both younger and less afflicted by comorbidity.
Among these cohorts of admitted patients, the one-year mortality was 11.9% after an ankle fracture and 28.2% after a hip fracture. In the control cohort, the one-year mortality after any other admission diagnosis was 21.5% (Fig. 2) . Parsing out the age subgroups by decade of life reveals the large variation in mortality across age groups (Fig. 3) . This correlation suggests that the difference in mortality rates in the fracture cohorts may largely be due to the difference in age distribution.
Without factoring in patient age or any comorbidities, the hazard ratio for one-year mortality after admission with an ankle fracture was 0.520 compared with the control (all other admissions) cohort. The same hazard ratio for patients with hip fracture was found to be 1.361 (Table III) . As suggested by the results above, these hazard ratios do not account for the substantial contributions of age and preexisting comorbidities. One-year survivorship following inpatient admission in the geriatric Medicare population for ankle fracture, hip fracture, and all other admitting diagnoses. One-year mortality after geriatric ankle fracture, hip fracture, and all other admissions in the Medicare population, combined and separated by age subgroups. The one-year mortalities for the ankle fracture cohort and the hip fracture cohort are significantly different overall and within each age subgroup at p < 0.001.
Sequential multivariate analyses separate and reveal the relative contributions of age, comorbidity, and injury to mortality. Factoring both fracture and age quantifies the substantial contribution of patient age to one-year mortality. Defining patients in the first decade of Medicare age eligibility of sixtyfive to seventy-four years as the reference group, the hazard ratio for mortality increases with each additional decade. Once the contribution of age is factored separately, the hazard ratio for a hip fracture falls to 1.088 and that of an ankle fracture changes only slightly to 0.551.
To avoid duplication, only one comorbidity index, the Elixhauser score, was chosen because of some evidence that it may be a better predictor of mortality than the Charlson-Deyo score [26] [27] [28] . Factoring comorbidities as represented by Elixhauser score demonstrates a substantial contribution but to a lesser degree than patient age.
Standardizing for both age and comorbidity, the hazard ratio for one-year mortality after admission was 1.081 for hip fracture and 0.557 for ankle fracture (compared with 1 for all other admissions). In other words, the hazard ratio for oneyear mortality after admission is higher for hip fracture but substantially lower for ankle fracture when compared with the average admission. This is best visually demonstrated by calculating survivorship standardizing to median age and median Elixhauser score to eliminate their contributions (Fig. 4) . In comparison with Figure 2 , which did not factor for age and comorbidities, the survivorship of patients with hip fracture in this standardized model approaches that of all other admissions, but that of patients with ankle fracture is relatively unchanged.
The secondary outcomes of morbidity were reflected by length of stay, disposition after discharge, readmissions, and thirty-day and ninety-day complications (Table IV) . The mean length of stay was significantly lower (p < 0.0001) for the ankle fracture cohort (4.6 days) compared with the hip fracture cohort (6.0 days). The mean discharge rate to a nursing home was also significantly lower (p < 0.0001) for the ankle fracture cohort (59.2%) compared with the hip fracture cohort *There was a significant difference at p < 0.001 between the ankle fracture cohort and the hip fracture cohort. †The values are given as the mean and the standard deviation, with the 95% confidence interval in parentheses. The confidence intervals were very tight because the standard errors of the mean all approached 0. ‡The values are given as the percentage of patients. Calculated one-year survivorship standardizing for age and comorbidities, set to a median age of seventy-five to eighty-four years and a median Elixhauser score of 2 points.
(71.4%). There were clinically similar but significantly different thirty-day readmission rates (p < 0.0001) between the ankle fracture cohort (13.3%) and the hip fracture cohort (15.0%). However, there was a significantly lower association (p < 0.0001) with thirty-day mortality rates for ankle fractures (1.9%) compared with hip fractures (6.8%). The two cohorts had essentially equivalent deep venous thrombosis rates (p = 0.5053), at 2.6% for the ankle fracture cohort compared with 2.7% for the hip fracture cohort. However, the rate of pulmonary embolus was significantly higher (p < 0.0001) in the hip fracture cohort (1.9%) compared with the ankle fracture cohort (0.9%). The rate of surgical site infections was significantly higher (p < 0.0001) in the 
ankle fracture cohort (3.6%) compared with the hip fracture cohort (1.5%). Otherwise, the ninety-day complication rate for the hip fracture cohort was significantly higher (p < 0.0001) for all other outcomes investigated.
Discussion
T he purpose of this study was to characterize the one-year mortality and morbidity rates associated with ankle fracture occurrence in the geriatric population when these injuries led to inpatient admission. Similarly available data on the elderly population with hip fracture were used as a comparator. Using Medicare Part A claims data helps to select geriatric patients with ankle fracture who require at least temporary hospitalization or other institutionalization secondary to a combination of their injury, immobilization, and non-weight-bearing status. This purposefully biases the data set and omits patients who are able to return home without any type of admission and who we believed to be physiologically younger than the patients whom this work was intended to assess.
Even after selecting for patients with ankle fracture who required inpatient admission, the demographic characteristics of the cohorts in this study revealed that when patients with ankle fracture were compared with patients with hip fracture, they tended to be younger, healthier, and less likely to have already had a nursing home admission. This difference in demographic characteristics is consistent with previously published work on geriatric ankle fractures that has identified younger age and higher physical activity level to be risk factors 8, 21, 22, 29 . Further support for differences between the two groups, although not elucidated in this study, is that obese geriatric women are at a threefold increased risk of sustaining ankle fractures but they are at a decreased risk of sustaining hip fractures 29 . Given the large differences in age and comorbidities among the cohorts, a direct comparison of one-year mortality is not particularly revealing, but is a good starting point and provides prognostic information. The primary outcome of one-year mortality of the ankle fracture cohort in this study (11.9%) was significantly less than both that of the hip fracture cohort (28.2%) and that of all other admissions (21.5%). The hip fracture mortality rate is consistent with that of previously published results that have hovered around 30% 18, 19 . The ankle fracture mortality rate is also similar to that of previously published studies (8.4% to 12%) 12, 20 . The mortality rate from the Medicare Part A claims in this study is on the higher end likely because of the intentional bias toward patients who required hospitalization.
To the best of our knowledge, this work represents the first effort to use a database for examining mortality after ankle fracture while factoring for both preexisting comorbidity burden and age cohort. After examination of the variation in one-year mortality across age groups for ankle fractures, hip fractures, and all other admissions, it becomes readily apparent that age is a major factor.
Factoring out the contributions of age and comorbidity by multivariate analysis brings the one-year mortality hazard ratio of hip fractures closer to that of any other admission. A substantial portion of the mortality associated with a hip fracture is therefore presumably due to a combination of the preexisting age and relative comorbidities of each patient. These results reinforce the common notion of a hip fracture as a sentinel event representing preexisting conditions. In contrast, the same multivariate analysis did not dramatically adjust the one-year mortality hazard ratio of ankle fractures. This difference suggests that selecting for patients with ankle fractures may also select for traits protective of morbidity beyond younger age and fewer comorbidities. The most likely candidate traits are general improved fitness and higher activity level, which are not reflected by simply adjusting for age and Elixhauser score. Previous studies have suggested that higher activity level is a risk factor for ankle fractures 8 . Any such difference in characterization between patients with ankle fracture and those with hip fracture becomes even more impressive when considering that this study was purposefully biased to exclude patients with ankle fracture who never required admission.
The secondary outcomes of ninety-day complications used as a proxy for morbidity need to be interpreted in the context of the underlying differences between the two cohorts, but can still be used to provide guidance to patients. The higher rate of surgical site infections in patients with ankle fracture compared with patients with hip fracture is consistent with general expectations for distal lower-extremity surgery. The equivalent rates of deep venous thrombosis between the hip fracture cohort and the ankle fracture cohort but the higher rate of pulmonary embolisms in the hip fracture cohort stand in contrast to prevailing opinion and are difficult to interpret. A difference in anatomic location of the deep venous thrombosis may be contributory, as distal deep venous thrombosis is believed to be less likely to propagate 30 . The choice of prophylactic regimens between the two cohorts remains unknown and likely differs, which further complicates any interpretation of this information.
The rate of pressure ulcers in the ankle fracture cohort was less than half that of the hip fracture cohort. This is interesting because the nature of immobility after these respective injuries is often quite different: distal immobilization with nonweight-bearing occurs most commonly for the ankle fracture population but weight-bearing as tolerated, albeit with discomfort, occurs most commonly for hip fractures postoperatively.
The rate for all other ninety-day complications was lower for ankle fractures compared with hip fractures. Similar to the findings for one-year mortality, these differences are likely largely due to the preexisting differences in age and comorbidity between the two cohorts.
This investigation had several strengths. All reported data were based on large population numbers and a well-captured data set. Incorporation of multivariate analysis accounted for the confounding variables of age and comorbidity, enabling better comparison of the different cohorts.
There were several limitations to this study that should be emphasized. The Medicare database presumably provides accurate data concerning age, mortality, discharges, and readmission.
However, the comorbidity indices rely on accurate ICD-9 coding. Furthermore, although the indices provide a convenient method of accounting for comorbidity, the individual contributions of specific conditions of interest such as peripheral vascular disease, diabetes, and nicotine use were not investigated.
The ninety-day complications, which were predominantly chosen as proxies for overall health, also depend on ICD-9 coding. Additionally, other than querying for surgical site infections, this study did not examine other local wound complications, failure of fixation, osteomyelitis, reoperation, or amputation.
This work confirms previously published one-year mortality rates for patients with ankle or hip fractures but creates an important distinction between patients with hip fracture and those with ankle fracture in the elderly population. Although the one-year morbidity of geriatric patients with hip fracture is largely a sign of preexisting age and health, ankle fractures in this population do not seem to represent this same type of sentinel event. In fact, it appears that ankle fractures are more likely to occur in geriatric patients with a lower risk of one-year mortality. These findings may support more aggressive and less expectant management of geriatric patients with ankle fractures because their mortality is lower than that of the average admitted geriatric patient. Overall, the results of this study might have important implications for providing additional guidance to patients and their providers during the care and decisionmaking process for their injuries. However, it is still recommended that these data be interpreted with caution, because the database represents a very large and heterogeneous patient population. The geriatric patient with ankle fracture who also presents with diabetes, neuropathy, or osteopenia continues to remain a treatment challenge. n
